Nature Medicine
March 2012, Volume 18 No 3 pp323-467
http://www.nature.com/nm/journal/v18/n3/index.html

Opinion
Public-private partnerships need honest brokering
Michel Goldman
doi:10.1038/nm0312-341

Given the current challenges in research and development, it’s increasingly apparent that collaboration between large pharmaceutical companies, academic teams and biotechnology enterprises is essential for converting basic biomedical discoveries into lifesaving medicines. But these partnerships work best when a neutral third party helps foster them.